evidencegaps
Primary study · included by 1 review

Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck.

Mix 2015 · Mix Michael, Singh Anurag K, Tills Michael, et al. · World journal of clinical oncology · 2015

Included by

Selenium supplementation for preventing cancer therapy-related toxicities: a systematic review and meta-analysis of clinical trials.
Non-Cochrane · intervention · 2026 · cited as Mix 2015 · Table 1; reference 23

The review does not say which of its outcomes this study informs.

1 including review in total.